A Tool to Improve Post-Operative Surgical Outcomes and Reduce Hospital Costs
Non-invasive System to Assist in Fluid Management
Technology Debuts at the 2011 American Society of Anesthesiologists Conference (ASA) October 15-17th, Booth #2242
BOTHELL, Wash.--(BUSINESS WIRE)-- SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today introduced the new BioZ® Cardio Profile system with impedance cardiography (ICG) technology for non-invasively monitoring a patient’s hemodynamic profile in the hospital. Pioneered by NASA in the 1960’s, ICG hemodynamic monitoring has traditionally been used to treat patients with heart failure and hypertension, and it is now ready to play a significant role in the anesthesia suite.
The BioZ Cardio Profile system offers a solution to one of the biggest challenges for anesthesiologists- non-invasively maintaining optimal intravascular (blood) volume during surgical procedures. By integrating the BioZ Cardio Profile system into surgical protocols, anesthesiologists will be able to impact post-operative complications, length of hospital stay, and costs associated with complications1. Furthermore, the BioZ provides a complete solution for treating patients at the point-of-care. Anesthesiologists can experience a demonstration of the BioZ Cardio Profile at the American Society of Anesthesiologists meeting on October 15-17th at the McCormick Place in Chicago.
The BioZ Cardio Profile Is One of the First
In comparison to other hemodynamic measuring tools, the BioZ product line with impedance cardiography technology is one of the first completely non-invasive solutions for fluid management. Traditionally, monitoring a patient’s hemodynamic profile required extremely invasive methods, including pulmonary artery catheterization. This type of catheter is typically placed in the intensive care unit and must be threaded through two heart valves and then placed into the pulmonary artery. With the high-risk nature of placing a pulmonary artery catheter, patients are more susceptible to infection, irregular heartbeats and rupture of the pulmonary artery. These complications can thus result in patient morbidity and mortality as well as increased hospital costs and hospital length of stay1. In contrast, ICG measurements are easily and safely obtained by simply placing skin sensors and reading the measurements on the device.
A world class medical institution is currently assessing the benefits of standardizing hemodynamic monitoring, including the BioZ Cardio Profile, for surgical procedures in the anesthesia suite. Gavin Martin, MB, CHB, Associate Professor of Anesthesiology, Duke Medical Center said, “Being a part of a hospital that is dedicated to providing the best in healthcare delivery, we look for technology that can better patient care and reduce complications. In assessing non-invasive cardiac output monitors, we are discovering that real-time hemodynamic assessment of our perioperative patients may lead to better post-surgical outcomes.”
The BioZ Cardio Profile is an important tool designed to help anesthesiologists successfully manage a patient’s fluid levels by monitoring the patient’s stroke volume as fluids are administered. As referenced in an article issued by the American Society of Anesthesiologists, a potential complication caused from the improper management of fluid, such as hypovolemia (decreased intravascular volume), may be a “potential cause of organ dysfunction, increased post-operative morbidity, and death.2”
The BioZ Cardio Profile can also be used for non-invasive hemodynamic monitoring in the emergency department and in critical care units, which may improve the treatment of heart failure and sepsis patients.
For more information about the BioZ Cardio Profile, please click here.
About SonoSite
SonoSite, Inc. (www.sonosite.com) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by fourteen subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.
1 Cannesson, Maxime, MD, PhD, and Patrice, MD Forget. "Fluid Responsiveness Monitoring in Surgical and Critically Ill Patients." Anesthesiology News (2010). Anesthesiology News. Web. <http://www.anesthesiologynews.com/download/SR1047FluidResponse_WM.pdf>.
2 Gan, Tong J., Andrew Soppitt, Mohamed Maroof, Habib El-Moalem, Kerri M. Robertson, Eugene Moretti, Peter Dwane, and Peter S. A. Glass. "Goal-directed Intraoperative Fluid Administration Reduces Length of Hospital Stay after Major Surgery." American Society of Anesthesiologists 97.4 (2002): 820-26. Print.
CONTACT:
SonoSite, Inc.
Lisa Fritzky, 425-951-1375
KEYWORDS: United States North America Illinois Washington
INDUSTRY KEYWORDS: Surgery Health Cardiology Hospitals Medical Devices General Health
MEDIA:
| Logo |